1 Min Read
March 19 (Reuters) - Apellis Pharmaceuticals Inc:
* APELLIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* APELLIS PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.61 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.